Lupin Launches CDMO Business and Names CEO To Head 

Lupin, a Mumbai, India-headquartered bio/pharmaceutical company, has announced the appointment of Abdelaziz Toumi as the CEO of its newly formed subsidiary and CDMO business, Lupin Manufacturing Solutions (LMS). LMS is focused on the development, manufacture, and sale of active pharmaceutical ingredients.  

Toumi has over two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. He has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma. He will be based in Switzerland and will spend considerable time in India. 

Source: Lupin